Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476554
Status:
TERMINATED
Last Update Posted:
2021-12-22
First Post:
2007-05-19
Brief Title:
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
Sponsor:
Cyclacel Pharmaceuticals Inc
Organization:
Cyclacel Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2012-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-19
First Submit QC Date:
May 19 2007
Study First Post Date:
2007-05-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-07
Last Update Post Date:
2021-12-22
Last Update Post Date Type:
ACTUAL